Ischemic tolerance and endogenous neuroprotection

Trends in Neurosciences

Volumn 26, Issue 5, 2003, Pages 248-254

  Dirnagl, Ulrich ^a   Simon, Roger P ^b   Hallenbeck, John M ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b RS Dow Neurobiology Laboratories   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BIOLOGICAL MODEL; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL MEDICINE; ENERGY METABOLISM; HUMAN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; STROKE; TISSUE INJURY; VELOCITY;

EID: 0038060334     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00071-7     Document Type: Review

References (78)

1. Janoff A. Alterations in lysosomes (intracellular enzymes) during shock; effects of preconditioning (tolerance) and protective drugs. Int. Anesthesiol. Clin. 2:1964;251-259.
2. Chen J., et al. Ischemic tolerance in the brain. Neurology. 48:1997;306-311.
3. Dawson V.L., et al. Neuronal ischaemic preconditioning. Trends Pharmacol. Sci. 21:2000;423-424.
4. Kirino T. Ischemic tolerance. J. Cereb. Blood Flow Metab. 22:2002;1283-1296.
5. Schaller B., et al. Cerebral ischemic preconditioning: an experimental phenomenon or a clinical important entity of stroke prevention? J. Neurol. 249:2002;1503-1511.
6. 2 deprivation in Drosophila: novel approaches using genetic models. Neuroscientist. 7:2001;538-550.
7. Dirnagl U., et al. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
8. Kitagawa K., et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528:1990;21-24.
9. Stagliano N.E., et al. Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 19:1999;757-761.
10. Prass K., et al. Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Res. 871:2000;146-150.
11. Zimmermann C., et al. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res. 895:2001;59-65.
12. Blondeau N., et al. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience. 109:2002;231-241.
13. Kobayashi S., et al. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15:1995;721-727.
14. Wiegand F., et al. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19:1999;1229-1237.
15. Chopp M., et al. Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurology. 39:1989;1396-1398.
16. Nishio S., et al. Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J. Neurosurg. 93:2000;845-851.
17. Galea E., et al. Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia. Am. J. Physiol. 274:1998;H2035-H2045.
18. Trendelenburg G., et al. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22:2002;5879-5888.
19. Weih M., et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke. 30:1999;1851-1854.
20. Moncayo J., et al. Do transient ischemic attacks have a neuroprotective effect? Neurology. 54:2000;2089-2094.
21. Schurr A., et al. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 374:1986;244-248.
22. Perez-Pinzon M.A., et al. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;175-182.
23. Dave K.R., et al. Ischemic preconditioning preserves mitochondrial function after global cerebral ischemia in rat hippocampus. J. Cereb. Blood Flow Metab. 21:2001;1401-1410.
24. Liu D., et al. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 22:2002;431-443.
25. Zhan R.Z., et al. Ischemic preconditioning is capable of inducing mitochondrial tolerance in the rat brain. Anesthesiology. 97:2002;896-901.
26. Jones N.M., et al. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J. Cereb. Blood Flow Metab. 21:2001;1105-1114.
27. Bernaudin M., et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22:2002;393-403.
28. Alkayed N.J., et al. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke. 33:2002;1677-1684.
29. Kapinya K.J., et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke. 33:2002;1889-1898.
30. + channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4666-4670.
31. Heemann U., et al. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am. J. Pathol. 156:2000;287-293.
32. Eising G.P., et al. Effects of induced tolerance to bacterial lipopolysaccharide on myocardial infarct size in rats. Cardiovasc. Res. 31:1996;73-81.
33. Bordet R., et al. Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J. Cereb. Blood Flow Metab. 20:2000;1190-1196.
34. Ohtsuki T., et al. Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 16:1996;1137-1142.
35. Wong G.H., et al. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242:1988;941-944.
36. Goodman Y., et al. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 66:1996;869-872.
37. Nawashiro H., et al. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17:1997;483-490.
38. Liu J., et al. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am. J. Physiol. Cell Physiol. 278:2000;C144-C153.
39. Ginis I., et al. TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-κB transactivation: the role of NF-κB association with p300 adaptor. J. Cereb. Blood Flow Metab. 22:2002;142-152.
40. Graham S.H., et al. Expression of the proto-oncogene bcl-2 is increased in the rat brain following kainate-induced seizures. Restor. Neurol. Neurosci. 9:2002;243-250.
41. Shimizu S., et al. bcl-2 Antisense treatment prevents induction of tolerance to focal ischemia in the rat brain. J. Cereb. Blood Flow Metab. 21:2001;233-243.
42. Walton M.R., et al. Is CREB a key to neuronal survival? Trends Neurosci. 23:2000;48-53.
43. Chen D., et al. Upregulation of mitochondrial base-excision repair capability within rat brain after brief ischemia. J. Cereb. Blood Flow Metab. 23:2003;88-98.
44. Wick A., et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 22:2002;6401-6407.
45. Prass K., et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22:2002;520-525.
46. ATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H1005-H1011.
47. Ferdinandy P., et al. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol. Sci. 19:1998;223-229.
48. von Arnim C.A., et al. Gender-dependent hypoxic tolerance mediated via gender-specific mechanisms. J. Neurosci. Res. 68:2002;84-88.
49. + channel. J. Mol. Cell. Cardiol. 29:1997;175-182.
50. Barone F.C., et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1998;1937-1950.
51. Kelly M.E., et al. Hippocampal kindling protects several structures from the neuronal damage resulting from kainic acid-induced status epilepticus. Brain Res. 634:1994;245-256.
52. Meldrum D.R. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J. Surg. Res. 73:1997;1-13.
53. Murry C.E., et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136.
54. Dahl N.A., et al. Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate. Am. J. Physiol. 1:1964;452-456.
55. Cohen M.V., et al. Ischemic preconditioning: from adenosine receptor of KATP channel. Annu. Rev. Physiol. 62:2000;79-109.
56. Bolli R. The late phase of preconditioning. Circ. Res. 87:2000;972-983.
57. Kloner R.A., et al. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation. 104:2001;2981-2989.
58. Tomai F., et al. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation. 100:1999;559-563.
59. Yellon D.M., et al. The preconditioning phenomenon: a tool for the scientist or a clinical reality? Circ. Res. 87:2000;543-550.
60. Nilsson G.E. Surviving anoxia with the brain turned on. News Physiol. Sci. 16:2001;217-221.
61. Frerichs K.U., et al. Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14511-14516.
62. Frerichs K.U., et al. Local cerebral blood flow during hibernation, a model of natural tolerance to 'cerebral ischemia'. J. Cereb. Blood Flow Metab. 14:1994;193-205.
63. Hochachka P.W., et al. Mechanism, origin, and evolution of anoxia tolerance in animals. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 130:2001;435-459.
64. Hermes-Lima M., et al. Animal response to drastic changes in oxygen availability and physiological oxidative stress. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 133:2002;537-556.
65. Bickler P.E., et al. Adaptive responses of vertebrate neurons to hypoxia. J. Exp. Biol. 205:2002;3579-3586.
66. Bickler P.E., et al. Molecular adaptations for survival during anoxia: lessons from lower vertebrates. Neuroscientist. 8:2002;234-242.
67. Storey K.B., et al. Metabolic rate depression and biochemical adaptation in anaerobiosis, hibernation and estivation. Q. Rev. Biol. 65:1990;145-174.
68. Lutz P.L., et al. Contrasting strategies for anoxic brain survival-glycolysis up or down. J. Exp. Biol. 200:1997;411-419.
69. Gentile N.T., et al. Decreased calcium accumulation in isolated nerve endings during hibernation in ground squirrels. Neurochem. Res. 21:1996;947-954.
70. Igelmund P., et al. Hibernation and hippocampal transmission. Geiser F., et al. Adaptations to the Cold: Tenth International Hibernation Symposium Armidale. 1996;159-165.
71. Spangenberger H., et al. Effects of adenosine on synaptic transmission in hippocampal slices from hibernating and warm-acclimated Turkish hamsters and rats. Neurosci. Lett. 185:1995;217-219.
72. Chang J., et al. Expression of heat shock proteins in turtle and mammal hearts: relationship to anoxia tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R209-R214.
73. Rice M.E., et al. Brain antioxidant regulation in mammals and anoxia-tolerant reptiles: balanced for neuroprotection and neuromodulation. Comp.Biochem. Physiol. C. Toxicol. Pharmacol. 133:2002;515-525.
74. Dawson T.M. Preconditioning-mediated neuroprotection through erythropoietin? Lancet. 359:2002;96-97.
75. Ruscher K., et al. Erythropoietin: a paracrine mediator of ischemic tolerance in the brain - evidence from an in vitro model of cerebral ischemia. J. Neurosci. 22:2002;10291-10301.
76. Siren A.L., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4044-4049.
77. Digicaylioglu M., et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature. 412:2001;641-647.
78. Ehrenreich H., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8:2002;495-505.